Alimenté par : Claudia (ADFI Alsace), Gaëlle (ADFI), Isabelle, Maïlé Onfray

Cet outil s'appuie sur PubMind

Un accès direct à la littérature scientifique via la base PubMed permettant de faciliter la veille sur les enjeux complexes de la santé mentale et du fait religieux : de la neuroscience des croyances à l'étude des abus spirituels, en passant par la prise en charge des traumatismes et des processus de déconversion.

Dernière synchronisation le 23/06/2026

Thérapies de Conversion

Pratiques visant à modifier l'orientation sexuelle ou l'identité de genre, illégales en France depuis la loi n°2022-92, et leurs effets psychologiques documentés.

500 articles disponibles

conversion therapy
sexual orientation change effort
SOCE harm
gender identity conversion
reparative therapy mental health
ex-gay therapy
conversion practice religious

Pathological complete response after conversion therapy in unresectable hepatocellular carcinoma: a retrospective study.

BACKGROUND: Hepatocellular carcinoma is a highly lethal tumor worldwide, and China has a correspondingly high incidence and mortality rate. For patients with unresectable hepatocellular carcinoma, the…

Thérapies de Conversion
Jia, J., Ding, C., Mao, M., Gao, F., Shao, Z., Zhang, M., & Zheng, S. (2024). Pathological complete response after conversion therapy in unresectable hepatocellular carcinoma: a retrospective study.. BMC Gastroenterol, 24(1), 242. https://doi.org/10.1186/s12876-024-03298-5
30/07/2024 Lire →

Hepatic arterial infusion chemotherapy combined with lenvatinib and PD-1 inhibitor for treating unresectable hepatocellular carcinoma.

The combination of lenvatinib and programmed cell death protein 1 (PD-1) inhibitor has demonstrated significant efficacy in treating unresectable hepatocellular carcinoma. Our study aimed to evaluate…

Thérapies de Conversion
Bai, Z., Yu, X., Tang, Q., Zhang, R., Shi, X., & Liu, C. (2024). Hepatic arterial infusion chemotherapy combined with lenvatinib and PD-1 inhibitor for treating unresectable hepatocellular carcinoma.. Br J Hosp Med (Lond), 85(7), 1-12. https://doi.org/10.12968/hmed.2024.0159
30/07/2024 Lire →

Conversion therapy for advanced biphenotypic hepatocellular carcinoma: A case report.

Thérapies de Conversion
Zhang, Y., Ma, Y., Wang, E., & Zhang, M. (2024). Conversion therapy for advanced biphenotypic hepatocellular carcinoma: A case report.. Asian J Surg. https://doi.org/10.1016/j.asjsur.2024.07.016
11/07/2024 Lire →

Predictive factors for transition to conversion therapy in HCC using atezolizumab plus bevacizumab.

Thérapies de Conversion
Chen, B., & Huang, B. (2024). Predictive factors for transition to conversion therapy in HCC using atezolizumab plus bevacizumab.. Liver Int, 44(7), 1735. https://doi.org/10.1111/liv.15944
01/07/2024 Lire →

Response to the letter: "Predictive factors for transition to conversion therapy in HCC using atezolizumab plus bevacizumab".

Thérapies de Conversion
Kikuchi, T., Takeuchi, Y., Nouso, K., Kariyama, K., Kuwaki, K., Toshimori, J., Iwado, S., Moriya, A., Hagihara, H., Takabatake, H., Tada, T., Yasunaka, T., Sakata, M., Sue, M., Miyake, N., Adachi, T., Wada, N., Onishi, H., Shiraha, H., … Otsuka, M. (2024). Response to the letter: "Predictive factors for transition to conversion therapy in HCC using atezolizumab plus bevacizumab".. Liver Int, 44(7), 1736-1737. https://doi.org/10.1111/liv.15964
01/07/2024 Lire →

Long-term survival of ALPPS procedure for hepatocellular carcinoma with tumor thrombus in the right branch of portal vein: A case report.

Thérapies de Conversion
Wang, Q. Q., Quan, X. L., Zhang, Y., & Shu, G. M. (2024). Long-term survival of ALPPS procedure for hepatocellular carcinoma with tumor thrombus in the right branch of portal vein: A case report.. Asian J Surg, 47(7), 3203-3204. https://doi.org/10.1016/j.asjsur.2024.03.111
01/07/2024 Lire →

Psychodynamic psychotherapy for gender dysphoria is not conversion therapy.

Over the last ten years, there has been a substantial increase in the number of children and adolescents referred to gender clinics for possible gender dysphoria. The gender affirming model of care, a…

Thérapies de Conversion
Sinai, J., & Sim, P. (2024). Psychodynamic psychotherapy for gender dysphoria is not conversion therapy.. J Can Acad Child Adolesc Psychiatry, 33(2), 145-153.
01/07/2024 Lire →

Reckoning With Our Past and Righting Our Future: Report From the Behavior Therapy Task Force on Sexual Orientation and Gender Identity/Expression Change Efforts (SOGIECEs).

Sexual orientation and gender identity/expression change efforts (SOGIECEs) are discredited practices that are associated with serious negative effects and incompatible with modern standards for clini…

Thérapies de Conversion
Comer, J. S., Georgiadis, C., Schmarder, K., Chen, D., Coyne, C. A., Gudiño, O. G., Kazantzis, N., Langer, D. A., LeBeau, R. T., Liu, R. T., McLean, C., Sloan, D. M., Williams, M. T., & Pachankis, J. E. (2024). Reckoning With Our Past and Righting Our Future: Report From the Behavior Therapy Task Force on Sexual Orientation and Gender Identity/Expression Change Efforts (SOGIECEs).. Behav Ther, 55(4), 649-679. https://doi.org/10.1016/j.beth.2024.05.006
01/07/2024 Lire →

Advancements in the Management of Synchronous Colorectal Liver Metastases: A Comprehensive Review of Surgical, Systemic, and Local Treatment Modalities.

PURPOSE OF REVIEW: This review addresses the current landscape of colorectal cancer (CRC) with a focus on liver metastases, the third most common cancer globally. It explores recent findings in treatm…

Thérapies de Conversion
KaraoÄźlan, B. B., Ă–z, D. K., Araz, M. S., Akyol, C., & Utkan, G. (2024). Advancements in the Management of Synchronous Colorectal Liver Metastases: A Comprehensive Review of Surgical, Systemic, and Local Treatment Modalities.. Curr Oncol Rep, 26(7), 791-803. https://doi.org/10.1007/s11912-024-01548-z
01/07/2024 Lire →

Conversion therapy for advanced hepatocellular carcinoma in the era of precision medicine: Current status, challenges and opportunities.

Hepatocellular carcinoma (HCC), the most prevalent malignancy of the digestive tract, is characterized by a high mortality rate and poor prognosis, primarily due to its initial diagnosis at an advance…

Thérapies de Conversion
Wang, M. D., Xu, X. J., Wang, K. C., Diao, Y. K., Xu, J. H., Gu, L. H., Yao, L. Q., Li, C., Lv, G. Y., & Yang, T. (2024). Conversion therapy for advanced hepatocellular carcinoma in the era of precision medicine: Current status, challenges and opportunities.. Cancer Sci, 115(7), 2159-2169. https://doi.org/10.1111/cas.16194
01/07/2024 Lire →

History and Iatrogenic Effects of Conversion Therapy.

Research indicates that sexual orientation change efforts (SOCEs) are not effective and furthermore commonly lead to iatrogenic effects such as depression, anxiety, and even suicide. Negative attitude…

Thérapies de Conversion
Davison, G. C., & Walden, K. R. (2024). History and Iatrogenic Effects of Conversion Therapy.. Annu Rev Clin Psychol, 20(1), 333-354. https://doi.org/10.1146/annurev-clinpsy-080822-052144
01/07/2024 Lire →

Conversion therapy of a giant hepatocellular carcinoma with portal vein thrombus and inferior vena cava thrombus: A case report and review of literature.

BACKGROUND: The prognosis of hepatocellular carcinoma (HCC) combined with portal and hepatic vein cancerous thrombosis is poor, for unresectable patients the combination of targeted therapy and immune…

Thérapies de Conversion
Song, W. J., Xu, J., Nie, Y., Li, W. M., Li, J. P., Yang, L., Wei, M. Q., & Tao, K. S. (2024). Conversion therapy of a giant hepatocellular carcinoma with portal vein thrombus and inferior vena cava thrombus: A case report and review of literature.. World J Clin Cases, 12(16), 2847-2855. https://doi.org/10.12998/wjcc.v12.i16.2847
06/06/2024 Lire →